Pentafluranol
![]() | |
| Clinical data | |
|---|---|
| ATC code | None |
| Identifiers | |
| |
| CAS Number | 65634-39-1 |
| PubChem (CID) | 3047826 |
| ChemSpider | 16737041 |
| UNII | 95RFZ48151 |
| ChEMBL | CHEMBL2105409 |
| Chemical and physical data | |
| Formula | C17H15F5O2 |
| Molar mass | 346.291816 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
Pentafluranol (INN, BAN) (developmental code name BX-430) is a synthetic, non-steroidal estrogen of the stilbestrol group related to diethylstilbestrol that was developed for the treatment of benign prostatic hyperplasia never marketed.[1][2] It was described in the medical literature in 1974.[1]
See also
References
- 1 2 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 1161. ISBN 978-1-4757-2085-3.
- ↑ Polska Akademia Nauk. Komitet Badania Polonii (1984). II Kongres Uczonych Polskiego Pochodzenia: zbiór materiałów. Zakład Narodowy im. Ossolińskich. p. 451. ISBN 978-83-04-01670-5.
This article is issued from Wikipedia - version of the 11/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
